Insights
Median is a disrupter in the area of medical imaging analysis. Find out more about what we are doing and how our technology works.
Conferences
February 10 to 12Immuno-Oncology 360°
Visit our team at booth #21 to learn about our best-in-class central imaging services for oncology clinical trials and how we are leveraging the latest in AI-powered imaging intelligence
Webinars
Closing the Gap: Strategies for Resolving Imaging Discrepancies in Oncology Drug Trials
Articles
Imaging at the Core of Radiopharmaceutical Oncology Trials
In the rapidly advancing landscape of precision oncology, radiopharmaceuticals are driving a paradigm shift. This class of therapy is revolutionizing cancer care by merging the pinpoint accuracy of diagnostic imaging with the potent, targeted impact of radionuclide therapy.
Brochures
eyonis™
End-to-end AI/ML tech-based CADe/CADx SaMD
Scientific publications
AI-assisted Lung Cancer Screening: Results from REALITY, a pivotal validation study of an AI/ML-based software
Presented at the American Thoracic Society Congress in San Francisco
Case studies
Accelerating Site Startups Across the Globe for Oncology Clinical Trial Imaging
White papers
Patient’s Body Composition in Oncology Trials: A Case for Implementation
Developed in collaboration with Syneos Health, this white paper explores the barriers preventing its widespread adoption, including challenges related to clinical evidence, accessibility of assessment tools, usability, and cost-effectiveness.